See every side of every news story

Browser Extension

Wednesday, April 9, 2025

US Edition

Subscribe Login

Israel-Hamas Conflict

Artificial Intelligence

Natural Disasters

Republican Party

Democratic Party

Merck.com image

News from Merck.com

News Home Page Local News Blindspot Feed International Covid-19

International North America South America Europe Asia Australia Africa

Trending Internationally Tariffs Donald Trump Trade War Social Media Artificial Intelligence

Trending in U.S.Israel-Hamas Conflict Baseball US Politics Tariffs Republican Party

Trending in U.K.Israel-Hamas Conflict UK Economy Soccer Tariffs Manchester United

Trending Topics

Tariffs Donald Trump Trade War Social Media Israel-Hamas Conflict

CompanyAbout History Mission Blog Testimonials Group Subscriptions Subscribe Gift Free Trial Careers Affiliates

HelpHelp Center FAQ Contact Us For Educators/Libraries Media Bias Ratings Ownership and Factuality Ratings Referral Code News Sources Topics

ToolsApp Browser Extension Daily Newsletter Blindspot Report Newsletter Burst Your Bubble Newsletter Timelines

Gift Privacy Policy Manage Cookies Terms and Conditions

© 2025 Snapwise Inc

Search Blindspot Local

Top Merck.com News

Merck’s PAH drug cuts risk of serious events by 76% in trial stopped for efficacy

Merck’s PAH drug cuts risk of serious events by 76% in trial stopped for efficacy

100% Center coverage: 2 sources

New data unveiled Monday showed that Merck’s Winrevair can significantly cut the risk of death, lung transplantation and hospitalization in patients with a rare form of high blood pressure in the lungs, potentially providing a boost to sales.See the Story

You've scrolled to the bottom of the feed, there are no more stories.

News from Merck.com

Stay current with all the latest and breaking news from Merck.com. Compare headlines and media bias behind news outlets on stories breaking today.

Ground News has come across 1 headlines reported on by Merck.com during the past 3 months.

We’ve assigned a media bias rating of to Merck.com. You can read more about our methodology here.

Is Merck.com credible or reliable? Our Factuality score answers both of those questions. When it comes to Merck.com, we’ve assigned a Unknown factuality rating. Ratings are assigned by aggregating scores from Ad Fontes Media and Media Bias/Fact Check.

Stay current with all the latest and breaking news from Merck.com. Compare headlines and media bias behind news outlets on stories breaking today. Ground News has come across 1 headlines reported on by Merck.com during the past 3 months.

We’ve assigned a media bias rating of to Merck.com. You can read more about our methodology here. Is Merck.com credible or reliable? Our Factuality score answers both of those questions. When it comes to Merck.com, we’ve assigned a Unknown factuality rating. Ratings are assigned by aggregating scores from Ad Fontes Media and Media Bias/Fact Check.

Information about Merck.com

Where is Merck.com located?Merck.com's Website

Media Bias Ratings

Do you diasgree?

Edit bias

Learn more about Media Bias Ratings.

Factuality

Learn more about Factuality Ratings

Reveal Factuality Ratings by upgrading to a Premium account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Ownership

Learn more about Ownership categories

Reveal Ownership Data by upgrading to a Vantage account.

Tap Upgrade to explore subscription options to meet all your reading needs.